Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Risicotolerantie onder MS-patiënten varieert enorm
apr 2019 | Multipele Sclerose